AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, ...
Updated data for casdatifan in late-line kidney cancer demonstrated median progression-free survival (PFS) of 15.1 months and a confirmed overall response rate (cORR) of 45% for the 100mg once-daily ...
Fourth Quarter and Full Year 2025 Revenue and Adjusted EBITDA Results In-line with Previous GuidancePharma Direct Revenue Beats Previous Outlook with Over 40% Year-Over-Year Growth for 2025SANTA ...
Leveragen, Inc., a Boston-based biotechnology company advancing next-generation in vivo antibody discovery, announced today ...
Durable royalties portfolio generated $58.4 million in revenue for the fourth quarter and $250.3 million for the full yearIST achieved U.S. net product sales of $33.9 million for the fourth quarter ...
March 10 product launch event offers practical AI, digital care, and medical-grade computing innovationsLAS VEGAS--(BUSINESS WIRE)--#HIMMS26--HIMSS 2026 -- Taiwan Excellence will make its first-ever ...
NDA for rusfertide submitted to the US Food and Drug Administration (FDA), with potential approval and launch this yearCompany expects to opt-out of the 50:50 profit and loss sharing arrangement for ...
Global Sciatica Market OverviewThe global sciatica market is projected to experience robust expansion over the next five ...
Market Overview and Growth OutlookThe global mHealth monitoring and diagnostic medical devices market is poised for strong ...
Overview: The global Artificial Intelligence (AI) in drug discovery market is projected to grow at a rate of 25-30% over the ...
The Pharmerging Market refers to the rapidly expanding pharmaceutical sectors in emerging economies, fueled by rising ...
The Gene Synthesis Market has emerged as one of the most transformative segments within modern biotechnology, driven by rapid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results